Literature DB >> 18771756

Tregs are regulated by cytokines: implications for autoimmunity.

Antonio La Cava1.   

Abstract

Several immune cell subsets contribute to the maintenance of peripheral tolerance by taking active participation in the networks that suppress autoreactive immune responses. There is ample evidence that CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) can have an important role in suppressing the production of autoimmune responses in animal models and in humans. This review describes the influences that specific cytokines have on the differentiation, maintenance and survival of Tregs, and how these effects can ultimately directly influence both number and functional activity of these cells in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771756      PMCID: PMC2583407          DOI: 10.1016/j.autrev.2008.08.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  40 in total

1.  IL-1 beta breaks tolerance through expansion of CD25+ effector T cells.

Authors:  Brendan J O'Sullivan; Helen E Thomas; Saparna Pai; Pere Santamaria; Yoichiro Iwakura; Raymond J Steptoe; Thomas W H Kay; Ranjeny Thomas
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 3.  Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.

Authors:  Franck Verrecchia; Alain Mauviel; Dominique Farge
Journal:  Autoimmun Rev       Date:  2006-07-05       Impact factor: 9.754

Review 4.  Disruption of immunological tolerance: role of AIRE gene in autoimmunity.

Authors:  M Rizzi; F Ferrera; G Filaci; F Indiveri
Journal:  Autoimmun Rev       Date:  2005-09-13       Impact factor: 9.754

5.  IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

Authors:  Emmanuel Zorn; Erik A Nelson; Mehrdad Mohseni; Fabrice Porcheray; Haesook Kim; Despina Litsa; Roberto Bellucci; Elke Raderschall; Christine Canning; Robert J Soiffer; David A Frank; Jerome Ritz
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

6.  IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions.

Authors:  Suigui Wan; Changqing Xia; Laurence Morel
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

7.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

8.  IL-2 receptor alpha deficiency and features of primary biliary cirrhosis.

Authors:  Christopher A Aoki; Chaim M Roifman; Zhe-Xiong Lian; Christopher L Bowlus; Gary L Norman; Yehuda Shoenfeld; Ian R Mackay; M Eric Gershwin
Journal:  J Autoimmun       Date:  2006-08-10       Impact factor: 7.094

9.  Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.

Authors:  Xin Chen; Monika Bäumel; Daniela N Männel; O M Zack Howard; Joost J Oppenheim
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

10.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.

Authors:  Xavier Valencia; Geoffrey Stephens; Raphaela Goldbach-Mansky; Mildred Wilson; Ethan M Shevach; Peter E Lipsky
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

View more
  26 in total

1.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

2.  Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.

Authors:  Xiyuan Zhang; Katherine L Cook; Anni Warri; Idalia M Cruz; Mariana Rosim; Jeffrey Riskin; William Helferich; Daniel Doerge; Robert Clarke; Leena Hilakivi-Clarke
Journal:  Clin Cancer Res       Date:  2017-02-01       Impact factor: 12.531

Review 3.  Natural regulatory T cells in autoimmunity.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Autoimmunity       Date:  2010-11-23       Impact factor: 2.815

4.  Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.

Authors:  Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

Review 5.  Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases.

Authors:  Xiaohui Zhou; Ning Kong; Hejian Zou; David Brand; Xianpei Li; Zhongmin Liu; Song Guo Zheng
Journal:  Autoimmunity       Date:  2010-07-29       Impact factor: 2.815

Review 6.  CD8+ Tregs in lupus, autoimmunity, and beyond.

Authors:  Ravi K Dinesh; Brian J Skaggs; Antonio La Cava; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-10       Impact factor: 9.754

Review 7.  Regulatory T Cells in SLE: Biology and Use in Treatment.

Authors:  Sophia Giang; Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

Review 8.  Modulation of autoimmunity with artificial peptides.

Authors:  Antonio La Cava
Journal:  Autoimmun Rev       Date:  2010-08-31       Impact factor: 9.754

9.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

10.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.